Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BSG | P35613 | 1/20 | 0.58 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pseudolaric Acid B SCHEMBL29357444 | 1.00 | BSG (0.58) | BSGCRBN | |
| Pseudolaric Acid B SCHEMBL29367226 | 1.00 | BSG (0.58) | BSGCRBN | |
| Pseudolaric Acid A SCHEMBL29785336 | 0.88 | BSG (0.47) | BSGCRBN | |
| Pseudolaric Acid A SCHEMBL27964349 | 0.88 | BSG (0.47) | BSGCRBN | |
| Pseudolaric Acid C SCHEMBL29754805 | 0.87 | BSG (0.46) | BSGCRBN | |
| Pseudolaric Acid C SCHEMBL28774868 | 0.87 | BSG (0.46) | BSGCRBN | |
| SCHEMBL28845305 | 0.86 | BSG (0.45) | BSGCRBN | |
| SCHEMBL18561099 | 0.77 | BSG (0.47) | BSGCRBN | |
| SCHEMBL16429224 | 0.74 | BSG (0.37) | BSGCRBN | |
| SCHEMBL8255709 | 0.57 | CHRM3 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10960078-B2 | Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2021-03-30 | — | — | US | disclosed |
| US-10463743-B2 | Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2019-11-05 | — | — | US | disclosed |
| US-20170056506-A1 | AMPHIPHILIC DRUG-DRUG CONJUGATES FOR CANCER THERAPY, COMPOSITIONS AND METHODS OF PREPARATION AND USES THEREOF | UNIV SHANGHAI JIAOTONG (CN) | 2017-03-02 | — | — | US | disclosed |
| US-20170056506-A1 | AMPHIPHILIC DRUG-DRUG CONJUGATES FOR CANCER THERAPY, COMPOSITIONS AND METHODS OF PREPARATION AND USES THEREOF | UNIV SHANGHAI JIAOTONG (CN) | 2017-03-02 | — | — | US | disclosed |
| US-9533054-B2 | Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2017-01-03 | — | — | US | disclosed |
| US-20150031644-A1 | AMPHIPHILIC DRUG-DRUG CONJUGATES FOR CANCER THERAPY, COMPOSITIONS AND METHODS OF PREPARATION AND USES THEREOF | UNIV SHANGHAI JIAOTONG (CN) | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170056506-A1 | AMPHIPHILIC DRUG-DRUG CONJUGATES FOR CANCER THERAPY, COMPOSITIONS AND METHODS OF PREPARATION AND USES THEREOF | ABCB4, ABCB1, LCAT | BSG 218/4885CRBN 2085/4885 |
| US-10463743-B2 | Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof | ABCB4, ABCB1, LCAT | BSG 218/4885CRBN 2085/4885 |
| US-10960078-B2 | Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof | ABCB4, ABCB1, LCAT | BSG 218/4885CRBN 2085/4885 |
| US-20150031644-A1 | AMPHIPHILIC DRUG-DRUG CONJUGATES FOR CANCER THERAPY, COMPOSITIONS AND METHODS OF PREPARATION AND USES THEREOF | ABCB4, ABCB1, LCAT | BSG 218/4885CRBN 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.